Finance

Lists
Why is WVE down 5,88%?
Dive Deeper
WVE:NASDAQ
Wave Life Sciences, Inc
USD 2,56
-5,88%
(-0,16) 1D
USD 2,60
+1,56% (+0,040)
After hours
Closed: 20 Nov., 16:00:01 GMT-5  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for WVE...
Open
USD 2,65
High
USD 2,79
Low
USD 2,54
Mkt. cap
504,91 m.
Avg. vol.
2,86 m.
Volume
2,28 m.
52-wk high
USD 21,73
52-wk low
USD 2,54
EPS
-USD 1,07
Beta
-1,40
Shares outstanding
197,23 m.
No. of employees
317
Open
USD 2,65
High
USD 2,79
Low
USD 2,54
Mkt. cap
504,91 m.
Avg. vol.
2,86 m.
Volume
2,28 m.
52-wk high
USD 21,73
52-wk low
USD 2,54
EPS
-USD 1,07
Beta
-1,40
Shares outstanding
197,23 m.
No. of employees
317
News stories
From web sources and news partners
About Wave Life Sciences, Inc
CEO-
Employees317
Founded2012
Headquarters-
SectorHealth Care
IndustryPharmaceutical industry
Analyst ratings
Based on 15 analysts giving stock ratings to WVE in the past 3 months
Strong buy
Buy
14
Hold
1
Sell
0
12-month forecast
Based on 15 Wall Street analysts offering 12 month price targets for WVE in the last 3 months.
Highest
Current USD 2,56
USD 44,00 (+1 618,75%)
Average
USD 16,57 (+547,27%)
Lowest
USD 8,37 (+226,95%)
Analyst
Recommendation
Action
Price target
Projected
Date
Ananda Ghosh
H.C. Wainwright
Buy
Maintained
USD 13,00
+407,8%
11/17/2026
Samantha Semenkow
Citi
Buy
Maintained
USD 15,00
+485,9%
11/12/2026
Madison Elsaadi
B. Riley Securities
Buy
Maintained
USD 18,00
+603,1%
11/09/2026
Whitney Ijem
Canaccord Genuity
Buy
Maintained
USD 44,00
+1 618,8%
11/04/2026
Yun Zhong
Wedbush
Buy
Maintained
USD 12,00
+368,7%
11/04/2026
Alec Stranahan
Bank of America Securities
Buy
Reiterated
USD 16,00
+525%
11/04/2026
Cheng Li
Oppenheimer
Buy
Maintained
USD 29,00
+1 032,8%
10/28/2026
Andrew Fein
H.C. Wainwright
Buy
Maintained
USD 13,00
+407,8%
10/28/2026
Luca Issi
RBC Capital
Buy
Maintained
USD 15,00
+485,9%
10/27/2026
Benjamin Burnett
Wells Fargo
Buy
Maintained
USD 14,00
+446,9%
10/28/2026
Joon Lee
UBS
Buy
Reiterated
USD 11,00
+329,7%
10/28/2026
Joseph Schwartz
Leerink Partners
Buy
Reiterated
USD 10,00
+290,6%
10/29/2026
Unknown Analyst
UBS
Buy
Initiated
USD 11,00
+329,7%
10/20/2026
Unknown Analyst
William Blair
Buy
Initiated
USD 8,37
+227%
10/15/2026
Alethia Young
William Blair
Buy
Initiated
USD 8,37
+227%
10/15/2026
Sharon Zackfia
William Blair
Buy
Initiated
USD 8,37
+227%
10/15/2026
Danielle Brill
Truist Financial
Buy
Maintained
-
-
10/02/2026
Rick Bienkowski
Ladenburg Thalmann & Co.
Buy
Initiated
USD 10,00
+290,6%
10/01/2026
Tessa Romero
J.P. Morgan
Hold
Downgraded
-
-
09/23/2026
Catherine Novack
JonesTrading
Buy
Reiterated
USD 30,00
+1 071,9%
08/07/2026
Salim Syed
Mizuho Securities
Buy
Maintained
USD 23,00
+798,4%
08/03/2026
Mara Goldstein
Clear Street
Buy
Maintained
USD 26,00
+915,6%
08/03/2026
William Maughan
Clear Street
Buy
Maintained
USD 26,00
+915,6%
08/03/2026
Unknown Analyst
B. Riley Securities
Buy
Reiterated
USD 22,00
+759,4%
07/31/2026
Steven Seedhouse
Cantor Fitzgerald
Buy
Maintained
USD 13,00
+407,8%
05/18/2026
Mohit Bansal
Wells Fargo
Buy
Maintained
USD 13,00
+407,8%
04/01/2026
Tiago Fauth
Raymond James
Buy
Maintained
USD 13,00
+407,8%
03/27/2026
Roger Song
Jefferies
Buy
Reiterated
USD 18,00
+603,1%
03/26/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Des. 2025
Mrt. 2026
Jun. 2026
Sep. 2026
Revenue
17,24 m.
38,25 m.
2,27 m.
13,16 m.
Cost of goods sold
52,81 m.
47,44 m.
51,29 m.
53,84 m.
Cost of revenue
52,81 m.
47,44 m.
51,29 m.
53,84 m.
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
20,90 m.
22,10 m.
24,78 m.
25,36 m.
Operating expense
20,90 m.
22,10 m.
24,78 m.
25,36 m.
Total operating expenses
73,71 m.
69,54 m.
76,07 m.
79,20 m.
Operating income
-56,47 m.
-31,30 m.
-73,80 m.
-66,05 m.
Other non operating income
234,00 k
-80,00 k
-275,00 k
-243,00 k
EBT including unusual items
-53,18 m.
-26,09 m.
-69,36 m.
-61,91 m.
EBT excluding unusual items
-53,18 m.
-26,09 m.
-69,36 m.
-61,91 m.
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-53,18 m.
-26,09 m.
-69,36 m.
-61,91 m.
Net profit margin
-308,37%
-68,21%
-3 052,60%
-470,53%
Earnings per share
-0,30
-0,13
-0,34
-0,30
Interest and investment income
3,05 m.
5,29 m.
4,72 m.
4,38 m.
Interest expense
-
-
-
-
Net interest expenses
3,05 m.
5,29 m.
4,72 m.
4,38 m.
Depreciation and amortization charges
-
-
-
-
EBITDA
-55,62 m.
-30,46 m.
-72,94 m.
-65,17 m.
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
Upcoming events
AI content may include mistakes. Learn more
Google-programme